Yusuf Tamam

821 total citations
45 papers, 608 citations indexed

About

Yusuf Tamam is a scholar working on Pathology and Forensic Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Yusuf Tamam has authored 45 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Yusuf Tamam's work include Multiple Sclerosis Research Studies (9 papers), Acute Ischemic Stroke Management (6 papers) and Protease and Inhibitor Mechanisms (3 papers). Yusuf Tamam is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Acute Ischemic Stroke Management (6 papers) and Protease and Inhibitor Mechanisms (3 papers). Yusuf Tamam collaborates with scholars based in Türkiye, Switzerland and Spain. Yusuf Tamam's co-authors include Kenan İltümür, Nebahat Taşdemir, Aziz Yaşan, Eşref Akıl, Abdullah Açar, Lut Tamam, Murat Orak, Aslan Güzel, Murat Terzi and Adalet Arıkanoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of the Neurological Sciences.

In The Last Decade

Yusuf Tamam

35 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuf Tamam Türkiye 15 141 124 104 95 85 45 608
Shuzo Shintani Japan 18 145 1.0× 62 0.5× 76 0.7× 83 0.9× 81 1.0× 74 872
Asuman Çelikbilek Türkiye 16 153 1.1× 116 0.9× 144 1.4× 86 0.9× 27 0.3× 40 722
Yajun Lian China 17 216 1.5× 92 0.7× 84 0.8× 192 2.0× 117 1.4× 68 818
Dong Hwan Yun South Korea 16 53 0.4× 98 0.8× 57 0.5× 106 1.1× 44 0.5× 46 727
Robert Patejdl Germany 14 53 0.4× 230 1.9× 102 1.0× 84 0.9× 51 0.6× 45 642
Fanyi Kong China 13 202 1.4× 57 0.5× 80 0.8× 68 0.7× 74 0.9× 42 501
Ilaria Maestrini Italy 12 304 2.2× 49 0.4× 127 1.2× 88 0.9× 47 0.6× 22 610
Ming‐Feng Liao Taiwan 15 120 0.9× 125 1.0× 49 0.5× 117 1.2× 41 0.5× 62 796
Zoltán Bajkó Romania 14 83 0.6× 109 0.9× 33 0.3× 78 0.8× 125 1.5× 68 592
Beata Łabuz-Roszak Poland 12 69 0.5× 144 1.2× 75 0.7× 35 0.4× 74 0.9× 87 466

Countries citing papers authored by Yusuf Tamam

Since Specialization
Citations

This map shows the geographic impact of Yusuf Tamam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuf Tamam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuf Tamam more than expected).

Fields of papers citing papers by Yusuf Tamam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuf Tamam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuf Tamam. The network helps show where Yusuf Tamam may publish in the future.

Co-authorship network of co-authors of Yusuf Tamam

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuf Tamam. A scholar is included among the top collaborators of Yusuf Tamam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuf Tamam. Yusuf Tamam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ünal, Aysun, Hüsnü Efendi, Mesrure Köseoğlu, et al.. (2023). Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting. Multiple Sclerosis and Related Disorders. 77. 104880–104880. 1 indexed citations
2.
Tamam, Yusuf, Cem İ̇smail Küçükali, Tuncay Gündüz, et al.. (2020). CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 48. 102697–102697. 13 indexed citations
3.
Bilgin, Mehmet, et al.. (2019). KORTİZON UYGULAMASINA DİRENÇLİ EL EGZAMA TEDAVİSİNDE DÜZENLEYİCİ YÖNTEMLER: OLGU SUNUMU. DergiPark (Istanbul University). 13(2). 36–39.
4.
Tamam, Yusuf, et al.. (2019). HİRUDOTERAPİ KOMPLİKASYONU OLARAK ENFEKSİYON OLGUSU. 13(1). 14–16. 1 indexed citations
5.
Tamam, Yusuf, et al.. (2019). Nöral tüp defektli hastalarda tek taraflı renal agenezi/displazi. SHILAP Revista de lepidopterología. 44(4). 1546–1548.
6.
Tamam, Yusuf, et al.. (2018). FARKLI BİR BOZUCU ALAN NEDENİ: HACAMAT. 12(1). 26–27. 1 indexed citations
7.
Özakbaş, Serkan, Recai Türkoğlu, Yusuf Tamam, et al.. (2018). Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial. Multiple Sclerosis and Related Disorders. 22. 70–76. 28 indexed citations
8.
Tamam, Yusuf, et al.. (2017). Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale. Multiple Sclerosis Journal - Experimental Translational and Clinical. 3(3). 2452148708–2452148708. 29 indexed citations
9.
Çoban, Arzu, et al.. (2017). Investigation of the prognostic value of adipokines in multiple sclerosis. Multiple Sclerosis and Related Disorders. 15. 11–14. 18 indexed citations
10.
Özdemіr, Hasan, Eşref Akıl, Abdullah Açar, et al.. (2016). Changes in serum albumin levels and neutrophil–lymphocyte ratio in patients with convulsive status epilepticus. International Journal of Neuroscience. 127(5). 417–420. 29 indexed citations
11.
Tamam, Yusuf, et al.. (2015). PERİFERİK YÜZ FELCİ TANI-TEDAVİSİ ve BİR OLGUYA NÖRALTERAPİ YAKLAŞIMI. 9(3). 23–26.
12.
Tamam, Yusuf, et al.. (2013). Role of Myeloperoxidase in Stroke. DergiPark (Istanbul University). 22(1). 1–11. 1 indexed citations
13.
Yaşan, Aziz, et al.. (2009). Predictive Factors for Acute Stress Disorder and Posttraumatic Stress Disorder after Motor Vehicle Accidents. Psychopathology. 42(4). 236–241. 36 indexed citations
14.
Tamam, Yusuf, et al.. (2009). Apolipoprotein E Genotype in Patients with Cerebrovascular Diseases and its Effect on the Disease Outcome. International Journal of Neuroscience. 119(7). 919–935. 5 indexed citations
15.
Tamam, Yusuf, et al.. (2008). Post‐stroke sexual functioning in first stroke patients. European Journal of Neurology. 15(7). 660–666. 60 indexed citations
16.
Taşdemir, Nebahat, et al.. (2008). Association of Apolipoprotein E Genotype and Cerebrovascular Disease Risk Factors in a Turkish Population. International Journal of Neuroscience. 118(8). 1109–1129. 4 indexed citations
17.
Tamam, Yusuf, et al.. (2007). Effect of rivastigmine on regional cerebral blood flow in Alzheimer’s disease. Advances in Therapy. 24(3). 611–621. 4 indexed citations
18.
Çelen, Mustafa Kemal, et al.. (2006). Multiresistant bacterial colonization due to increased nurse workload in a neurology intensive care unit.. PubMed. 11(4). 265–70. 9 indexed citations
19.
Taşdemir, Nebahat & Yusuf Tamam. (2005). Bir Olgu Nedeniyle Abdominal Epilepsi. 32(1). 31–35. 1 indexed citations
20.
Taşdemir, Nebahat & Yusuf Tamam. (2005). Abdominal Epilepsy: A Case Report. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026